Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-05-05
|
laquinimod |
relapsing-remitting multiple sclerosis (RRMS) |
3 |
Teva Pharmaceuticals (Israel) Active Biotech (Sweden) |
Autoimmune diseases - Neurodegenerative diseases |
2017-05-05
|
metreleptin (analog of the human hormone leptin) |
generalized lipodystrophy |
|
Novelion Therapeutics |
Hepatic diseases - Liver diseases |
2017-05-04
|
HB-101 |
cytomegalovirus infections |
1 |
Hookipa Biotech (Austria) |
Infectious diseases |
2017-05-04
|
emricasan |
NASH (non-alcoholic steatohepatitis) |
2b |
Conatus Pharmaceuticals (USA - CA) |
Hepatic diseases - Liver diseases |
2017-05-04
|
OMP-313M32 (anti-TIGIT) |
solid tumors |
1 |
OncoMed Pharmaceuticals (USA - CA) |
Cancer - Oncology |
2017-05-04
|
StrataGraft® regenerative skin tissue |
healing of excised full-thickness complex skin defects resulting from acute traumatic skin loss |
2 |
Mallinckrodt (UK) |
Dermatological diseases |
2017-05-04
|
ADC-1013/JNJ-64457107 |
|
preclinical |
Alligator Bioscience (Sweden) |
|
2017-05-04
|
ARGX-113 |
myasthenia gravis |
2 |
Argen-X (Belgium - The Netherlands) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2017-05-03
|
resminostat (oral pan-histone deacetylase (HDAC) inhibitor) |
mycosis fungoides, Sezary syndrome, advanced-stage cutaneous T-cell lymphoma (CTCL). |
2 |
4SC (Germany) |
Cancer - Oncology |
2017-05-03
|
|
pain |
|
Grunenthal (Germany) 23andMe (USA - CA) |
CNS diseases - Neurological diseases |
2017-05-03
|
Sarconeos (formerly SARCOB BIO101) |
sarcopenic obesity |
2a |
Biophytis (France) |
Muscle disorders |
2017-05-03
|
RGT100 |
solid tumors, lymphoma |
1-2 |
Rigontec (Germany) |
Cancer - Oncology |
2017-05-02
|
Feraheme® (ferumoxytol) |
iron deficiency anemia (IDA) |
3 |
Amag Pharmaceuticals (USA - MA) |
Metabolic diseases |
2017-05-02
|
EB-101 (gene corrected skin grafts) |
epidermolysis bullosa |
1-2 |
Abeona Therapeutics (USA - NY) |
Rare diseases - Genetic diseases - Dermatological diseases |
2017-05-02
|
Baxdela® (delafloxacin) |
acute bacterial skin and skin structure infections (ABSSSI) |
3 |
Melinta Therapeutics (USA - CT) |
Infectious diseases |
2017-05-02
|
oral leptin capsule |
obesity |
|
Oramed Pharmaceuticals (Israel) |
Metabolic diseases |
2017-05-02
|
SENS-401 |
prevention of cisplatin-induced ototoxicity |
preclinical |
Sensorion (France) |
Otorhinolaryngology |
2017-05-02
|
GMI-1271, GMI-1359 |
breast cancer |
preclinical |
GlycoMimetics (USA - Md) |
Cancer - Oncology |
2017-05-01
|
TSR-033 |
|
1 |
Tesaro (US - MA) |
Cancer - Oncology |
2017-05-01
|
IMGN853 - mirvetuximab soravtansine |
FRalpha-positive platinum-resistant ovarian cancer |
1-2 |
Immunogen (USA - MA) |
Cancer - Oncology |